THE ANALYSIS OF DEBRISOQUINE POLYMORPHISM - AN OBJECTIVE APPROACH BASED ON PROBABILITY

被引:0
|
作者
LLEDO, P [1 ]
JACKSON, SHD [1 ]
JOHNSTON, A [1 ]
PEARSON, RM [1 ]
机构
[1] ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P232 / P233
页数:2
相关论文
共 50 条
  • [21] An efficient reliability analysis approach for structure based on probability and probability box models
    Liu, Xin
    Yin, Lairong
    Hu, Lin
    Zhang, Zhiyong
    STRUCTURAL AND MULTIDISCIPLINARY OPTIMIZATION, 2017, 56 (01) : 167 - 181
  • [22] An efficient reliability analysis approach for structure based on probability and probability box models
    Xin Liu
    Lairong Yin
    Lin Hu
    Zhiyong Zhang
    Structural and Multidisciplinary Optimization, 2017, 56 : 167 - 181
  • [23] COUNTING STEPS: A FINITIST APPROACH TO OBJECTIVE PROBABILITY IN PHYSICS
    Hagar, Amit
    Sergioli, Giuseppe
    EPISTEMOLOGIA, 2014, 37 (02): : 262 - 275
  • [24] DEBRISOQUINE POLYMORPHISM - MECHANISM FOR VERY RAPID OXIDATIVE PHENOTYPE
    AGUNDEZ, JAG
    BENITEZ, J
    LANCET, 1993, 341 (8846): : 689 - 689
  • [25] Probability-based unified sensitivity analysis for multi-objective performances of composite laminates: A surrogate-assisted approach
    Kushari, S.
    Mukhopadhyay, T.
    Chakraborty, A.
    Maity, S. R.
    Dey, S.
    COMPOSITE STRUCTURES, 2022, 294
  • [26] TIMOLOL METABOLISM AND DEBRISOQUINE OXIDATION POLYMORPHISM - A POPULATION STUDY
    LENNARD, MS
    LEWIS, RV
    BRAWN, LA
    TUCKER, GT
    RAMSAY, LE
    JACKSON, PR
    WOODS, HF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (04) : 429 - 434
  • [27] POLYMORPHISM OF DEBRISOQUINE OXIDATION IN NEW-ZEALAND CAUCASIANS
    WANWIMOLRUK, S
    DENTON, JR
    FERRY, DG
    BEASLEY, M
    BROUGHTON, JR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (03) : 349 - 350
  • [28] METHOXYPHENAMINE AND DEXTROMETHORPHAN AS SAFE PROBES FOR DEBRISOQUINE HYDROXYLATION POLYMORPHISM
    ROY, SD
    HAWES, EM
    HUBBARD, JW
    MCKAY, G
    MIDHA, KK
    LANCET, 1984, 2 (8416): : 1393 - 1393
  • [29] GENETIC-POLYMORPHISM OF SPARTEINE DEBRISOQUINE OXIDATION - A REAPPRAISAL
    LENNARD, MS
    PHARMACOLOGY & TOXICOLOGY, 1990, 67 (04): : 273 - 283
  • [30] The influence of the sparteine/debrisoquine genetic polymorphism on the disposition of dexfenfluramine
    Gross, AS
    Phillips, AC
    Rieutord, A
    Shenfield, GM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (04) : 311 - 317